FDA grants breakthrough status to Cidara’s flu drug Cidara Therapeutics' CD388, a long-acting influenza prophylactic, has previously received funding worth up to $339 million from the US BARDA.

The US FDA granted the drug Breakthrough Therapy designation to Cidara Therapeutics’ its investigational influenza prophylactic, CD388, for the prevention of influenza A and B in high-risk adults and adolescents.

#News #FluTherapy #CD388

FDA grants breakthrough status to Cidara’s flu drug Cidara Therapeutics' CD388, a long-acting influenza prophylactic, has previously received funding worth up to $339 million from the US BARDA.

The US FDA granted the drug Breakthrough Therapy designation to Cidara Therapeutics’ its investigational influenza prophylactic, CD388, for the prevention of influenza A and B in high-risk adults and adolescents.

#News #FluTherapy #CD388

Cidara secures $339m from BARDA for non-vaccine flu therapy Cidara Therapeutics wins BARDA backing to expand US manufacturing and clinical development of its long-acting, non-vaccine influenza therapeutic, CD388.

Cidara Therapeutics secures up to $339M from BARDA to expand U.S. manufacturing and clinical development of CD388, its long-acting, non-vaccine influenza preventative designed to offer broad protection against all flu strains.
#News #BARDA #InfluenzaPrevention #CD388 #Biotech #PandemicPreparedness

Cidara secures $339m from BARDA for non-vaccine flu therapy Cidara Therapeutics wins BARDA backing to expand US manufacturing and clinical development of its long-acting, non-vaccine influenza therapeutic, CD388.

Cidara Therapeutics secures up to $339M from BARDA to expand U.S. manufacturing and clinical development of CD388, its long-acting, non-vaccine influenza preventative designed to offer broad protection against all flu strains.
#News #BARDA #InfluenzaPrevention #CD388 #Biotech #PandemicPreparedness

Single antiviral shot could offer better protection than flu vaccines A long-lasting formulation of an antiviral drug greatly reduced people’s risk of a symptomatic flu infection in a trial, and should even be effective against new strains

New Super Flu AntiViral shot is in the works called #CD388, which contains the now longer lasting flu fighting drug #zanamivir. www.newscientist.com/article/2486...

"Cidara developed a chemical variant of the drug and attached several copies of it to a piece of an antibody called the Fc fragment"

#science
#zanamivir
#CD388
#influenza
76.1%

buff.ly/ywS3pM9

Could we solve influenza with a vast rotating stockpile of a universal long-lasting drug against seasonal and pandemic influenza?

My analysis of Cidara Therapeutics and CD388:
birdflustocks.substack.com/p/cidara-the...

#H5N1 #influenza #pandemic #CDTX #CD388